The IMF’s Understanding series of cancer information booklets is designed to acquaint you with specific multiple myeloma-related tests, treatments and therapies, supportive care measures, and common adverse events.

Due to current health and safety precautions, hard copy mailing of IMF publications are temporarily delayed up to several weeks. However, digital versions of all IMF publications are available below.

Order Print Edition


Full of our informative publications, including our Patient Handbook and selections from the popular Understanding Series, the Info Pack will…

Blenrep (belantamab mafodotin-blmf) is an antibody-drug conjugate (ADC), the first in a new class of treatments for myeloma. Blenrep is the…

This publication discusses what myeloma patients should consider if enrolling in a clinical trial.
This publication discusses the use of DARZALEX® (daratumumab) injection and DARZALEX FASPRO™ —for the treatment of myeloma.
This publication discusses the use of dexamethasone and other steroids for the treatment of myeloma, as well as possible steroid side effects.

We Thank Our Sponsors:
Amgen, GSK, Janssen, Karyopharm Therapeutics, Oncopeptides, Inc. and Takeda

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.